Jason L. Vassy, MD, MPH

Adjunct Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published 7/30/2026

    Bailey AV, Frochen S, Kwan L, Siavoshi M, Haroldsen CL, Shelton JB, Rose B, Maxwell KN, Nickols NG, Yamoah K, Rebbeck TR, Schoen MW, Rettig MB, Vassy JL, Garraway IP, Iyer HS. A Comparison of Prostate Cancer Incidence and Mortality Rates in the Veterans Affairs Healthcare system and the Surveillance, Epidemiology, and End Results Program. Cancer Epidemiol Biomarkers Prev. 2026 Jul 30. PMID: 42530444.

    Read at: PubMed

  • Published 5/26/2026

    Chen AS, Vassy JL. Transforming the Patient-Centered Medical Home: Reimagining Primary Care Through AI. J Gen Intern Med. 2026 May 26. PMID: 42192066.

    Read at: PubMed

  • Published 5/13/2026

    Xu G, Karunamuni R, Dornisch AM, Brunette CA, Danowski ME, Desai H, Dochtermann D, Garraway IP, Hauger RL, Kibel AS, Lynch JA, Pyarajan S, Rose BS, Teerlink CC, Andreassen OA, Dale AM, Donovan JL, Hamdy F, Kachuri L, Lane A, Martin RM, Mills IG, Neal DE, Turner EL, Witte JS, Schleutker J, Pashayan N, Batra J, Nordestgaard BG, Hamilton RJ, Wolk A, Albanes D, Atkins J, Blot WJ, Mucci LA, Nielsen SF, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Menegaux F, Park JY, MacInnis RJ, Rosenstein BS, Lu YJ, Watya S, Vega A, Kogevinas M, Wiklund F, Plym A, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ost P, Razack A, Fowke JH, Gamulin M, Usmani N, Claessens F, Castelao JE, Petrovics G, Parent MÉ, Hu JJ, Zheng W, Kote-Jarai Z, Eeles RA, Maxwell KN, Vassy JL, Seibert TM. Germline polygenic score for prostate cancer aggressiveness. medRxiv. 2026 May 13. PMID: 42145622.

    Read at: PubMed

  • Published 1/26/2026

    Vassy JL, Dornisch AM, Karunamuni R, Gatzen M, Kachulis CJ, Lennon NJ, Brunette CA, Danowski ME, Hauger RL, Garraway IP, Kibel AS, Lee KM, Lynch JA, Maxwell KN, Ratner D, Rose BS, Teerlink CC, Xu GJ, Hofherr SE, Lafferty KA, Larkin K, Malolepsza E, Patterson CJ, Toledo DM, Donovan JL, Hamdy FC, Martin RM, Neal DE, Turner EL, Andreassen OA, Dale AM, Mills IG, Abraham A, Batra J, Clements J, Cussenot O, Cybulski C, Eeles RA, Fowke JH, Grindedal EM, Grönberg H, Hamilton RJ, Lim J, Lu YJ, MacInnis RJ, Maier C, Mucci LA, Multigner L, Neuhausen SL, Nielsen SF, Parent MÉ, Park JY, Petrovics G, Plym A, Razack A, Rosenstein BS, Schleutker J, Sørensen KD, Townsend PA, Travis RC, Vega A, West CML, Wiklund F, Zheng W, Seibert TM. Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study. Nat Cancer. 2026 Feb; 7(2):352-367. PMID: 41588240.

    Read at: PubMed

  • Published 1/2/2026

    Vassy JL, Brunette CA, Yi T, Assimes TL, Christensen KD, Knowles JW, Sturm AC, Sun YV, Alexander N, Cardellino MP, Harrison A, Gerety HL, Pyatt M, Vered R, Wilson PWF, Natarajan P, Whitbourne SB, Gaziano JM, Muralidhar S, Danowski ME. Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 02; 9(1):e2549664. PMID: 41511773.

    Read at: PubMed

Education

  • Washington University School of Medicine, MD
  • Harvard School of Public Health, SM/ScM
  • Johns Hopkins University School of Public Health, MPH
  • Furman University, BS